The medical device industry appears to be under siege by cybercriminals, but it isn't taking steps to defend itself, according to two separate reports.

Scott Gottlieb, M.D., has ended the hiring freeze President Donald Trump imposed on the FDA.

The key to strengthening the lungs of premature babies may be held by spiders—namely, the way they spin their webs.

Researchers from the University of Rochester's Center for RNA Biology are investigating CRISPR/CAS9 as a way to slow the growth of cancer cells.

Alexion bids farewell to CFO, CCO, R&D head and HR chief; Illumina's interim CCO became permanent; INC Research unveiled new executive team.

Harpoon Therapeutics has raised $45 million in its second funding round as it looks to get its I-O candidates into the clinic as well as boosting its pipeline…

GW Pharma's cannabis-based epilepsy treatment Epidiolex is firmly on track for a filing in the U.S. after new data published in the New England Journal of…

Redx has suspended trading of its shares after a creditor stepped up its attempt to recoup a loan.

A panel of experts voted 12 to 4 in favor of approving Puma's breast cancer adjuvant therapy neratinib.

Merck has today penned a new licensing deal with Tokyo’s Teijin Pharma for its investigational tau-targeting antibody candidate in Alzheimer’s.